Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Xtant Medical Holdings (XTNT) Other financing activities (2018 - 2025)

Xtant Medical Holdings has reported Other financing activities over the past 6 years, most recently at $15000.0 for Q2 2025.

Quarterly Other financing activities fell 91.62% to $15000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $52000.0 through Sep 2025, down 92.67% year-over-year, with the annual reading at $651000.0 for FY2024, 172.38% up from the prior year.
Other financing activities was $15000.0 for Q2 2025 at Xtant Medical Holdings, down from $34000.0 in the prior quarter.
Over five years, Other financing activities peaked at $436000.0 in Q1 2024 and troughed at $3000.0 in Q4 2024.
The 4-year median for Other financing activities is $40000.0 (2023), against an average of $100555.6.
Year-over-year, Other financing activities surged 990.0% in 2024 and then tumbled 92.2% in 2025.
A 4-year view of Other financing activities shows it stood at $104000.0 in 2021, then plummeted by 41.35% to $61000.0 in 2023, then tumbled by 95.08% to $3000.0 in 2024, then surged by 400.0% to $15000.0 in 2025.
Per Business Quant, the three most recent readings for XTNT's Other financing activities are $15000.0 (Q2 2025), $34000.0 (Q1 2025), and $3000.0 (Q4 2024).